Takeo Naito
9PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Feb 06, 2026
HLA-DQB1*03:01 and HLA-DQA1*05:05 as key genetic determinants of infliximab response and immunogenicity in Japanese patients with inflammatory bowel disease.Ryuya Osaka, Takeo Naito, Seik-Soon Khor
|May 16, 2025
Evolving Trends in Pediatric Inflammatory Bowel Disease Management in Japan: A Decade of Nationwide Data.Miki Urushiyama, Kunio Tarasawa, Rintaro Moroi
|Jul 25, 2024
Chronic Poor Sleep is Associated with Increased Disease Activity in Patients with Ulcerative Colitis: Prospective Observational Study in Japan.Hideaki Oyama, Rintaro Moroi, Atsushi Sakuma
|Jun 30, 2024
Genetically Predicted Higher Levels of Caffeic Acid Are Protective Against Ulcerative Colitis: A Comprehensive Metabolome Analysis.Takeo Naito, Ryuya Osaka, Yoichi Kakuta
|Jun 18, 2024
Clinical practice and outcome of patients with elderly-onset ulcerative colitis: Insights from a nationwide claims database study in Japan.Rintaro Moroi, Yoichi Kakuta, Hiroshi Nagai
|Mar 27, 2024
Prescribing in pregnant women with inflammatory bowel disease and its relationship to congenital malformations in Japan.Sayumi Takahashi, Yoichi Kakuta, Taku Obara
Pageof 2
